<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04192279</url>
  </required_header>
  <id_info>
    <org_study_id>78247891400</org_study_id>
    <nct_id>NCT04192279</nct_id>
  </id_info>
  <brief_title>Early Lactate Clearance Rate in Sepsis</brief_title>
  <official_title>Monitoring and Guidance of Early Lactate Clearance Rate in Patients With Sepsis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The Second Hospital of Hebei Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The Second Hospital of Hebei Medical University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To assess the Influence of early lactate clearance rate monitoring in patients with sepsis.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 1, 2015</start_date>
  <completion_date type="Anticipated">February 15, 2020</completion_date>
  <primary_completion_date type="Anticipated">January 31, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>In-hospital 60days mortality</measure>
    <time_frame>In-hospital 60 days</time_frame>
    <description>In-hospital up to 60 days mortality of sepsis</description>
  </primary_outcome>
  <primary_outcome>
    <measure>ICU mortality</measure>
    <time_frame>up to 30 days</time_frame>
    <description>ICU up to 30 days mortality of sepsis</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">220</enrollment>
  <condition>Early Lactate Clearance</condition>
  <arm_group>
    <arm_group_label>lactate group</arm_group_label>
    <description>Lactate early guide resuscitation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control group</arm_group_label>
    <description>early guide resuscitation without lactate</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>lactate clearance</intervention_name>
    <description>Lactate clearance rate was monitored within 6 hours after admission</description>
    <arm_group_label>lactate group</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with severe sepsis or septic shock were recruited from Emergency ICU of the second
        hospital of Hebei Medical University.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All patients whose blood lactate level reached or exceeded 2.0 mEq / L

        Exclusion Criteria:

          -  Incomplete clinical data
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Fei Tong, Dr.</last_name>
    <phone>+8615803210603</phone>
    <email>tongfei168@163.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jiangqing Xu, Dr.</last_name>
    <phone>+8615732193221</phone>
    <email>jq745790350@163.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>The Second Hospital of Hebei Medical University</name>
      <address>
        <city>Shijiazhuang</city>
        <state>Hebei</state>
        <zip>050000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Fei Tong, Dr.</last_name>
      <phone>+8615803210603</phone>
      <email>tongfei168@163.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>December 2019</verification_date>
  <study_first_submitted>December 4, 2019</study_first_submitted>
  <study_first_submitted_qc>December 9, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">December 10, 2019</study_first_posted>
  <last_update_submitted>December 9, 2019</last_update_submitted>
  <last_update_submitted_qc>December 9, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">December 10, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>The Second Hospital of Hebei Medical University</investigator_affiliation>
    <investigator_full_name>Fei Tong</investigator_full_name>
    <investigator_title>Director</investigator_title>
  </responsible_party>
  <keyword>sepsis</keyword>
  <keyword>lactate</keyword>
  <keyword>early</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sepsis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

